Ian Garbarine, MD (he/him/his)

General Surgery Resident
Ohio State University
Columbus, Ohio, United States

Ian Garbarine, MD is a general surgery resident at The Ohio State University interested in surgical oncology, currently pursuing a research fellowship in the Carson Lab. His research focuses on tumor immunology, with particular interest in the role of myeloid-derived suppressor cells (MDSC) in immune evasion and leveraging novel combinatorial therapies to promote tumor clearance. He employs deep immunophenotyping using spectral flow cytometry, spatial transcriptomics, and bioinformatic techniques to characterize the tumor immune microenvironment and identify mechanisms of resistance to immune checkpoint blockade across solid tumors. He also applies AI/ML approaches to analyze real-world data to improve cancer care delivery. He plans to pursue a career in academic surgical oncology.

Presentation(s):

• P40. Receipt of adjuvant checkpoint inhibitor therapy for melanoma and risk of subsequent skin cancer

  Thursday, March 5, 2026
  2:18 PM - 2:25 PM MST

• P48. Duration of adjuvant immunotherapy in sentinel node positive melanoma: How important is completing a full year?

  Thursday, March 5, 2026
  3:14 PM - 3:21 PM MST

• BP4. Dasatinib reverses myeloid derived suppressor cell (MDSC) inhibition of T-cell proliferation in a triple negative breast cancer model

  Friday, March 6, 2026
  8:23 AM - 8:30 AM MST